Vaccines, blood, antisera, toxins and cultures in   Kazakhstan

Exports In 2022, Kazakhstan exported $4.61M in Vaccines, blood, antisera, toxins and cultures, making it the 85th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 309th most exported product in Kazakhstan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Kazakhstan are: Russia ($3.85M), Switzerland ($249k), Uzbekistan ($159k), Lithuania ($126k), and Kyrgyzstan ($69.6k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Kazakhstan between 2021 and 2022 were Russia ($1.27M), Lithuania ($126k), and Switzerland ($94.7k).

Imports In 2022, Kazakhstan imported $467M in Vaccines, blood, antisera, toxins and cultures, becoming the 58th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 17th most imported product in Kazakhstan. Kazakhstan imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($111M), Germany ($65.2M), Russia ($50.5M), France ($45.1M), and Ireland ($37.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Kazakhstan between 2021 and 2022 were Switzerland ($33.1M), France ($14.3M), and Germany ($13.6M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Kazakhstan to the United States.